Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals

(2019) Ilias Gountas et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era

(2019) Paolo Angelo Cortesi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

(2018) Kelly Safreed-Harmon et al.   SEMINARS IN LIVER DISEASE

Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review

(2017) S. H. I. HOFSTRAAT et al.   EPIDEMIOLOGY AND INFECTION

The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) subjects treated with all-oral elbasvir/grazoprevir regimens in the United States

(2016) E. H. Elbasha et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

(2016) Swathi Iyengar et al.   PLOS MEDICINE

Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009

(2015) Luis García Comas et al.   JOURNAL OF MEDICAL VIROLOGY

Global epidemiology and genotype distribution of the hepatitis C virus infection

(2014) Erin Gower et al.   JOURNAL OF HEPATOLOGY

Historical epidemiology of hepatitis C virus (HCV) in selected countries

(2014) P. Bruggmann et al.   JOURNAL OF VIRAL HEPATITIS

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

(2013) Shannon Allen Ferrante et al.   BMC INFECTIOUS DISEASES

The burden of liver disease in Europe: A review of available epidemiological data

(2013) Martin Blachier et al.   JOURNAL OF HEPATOLOGY

The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010

(2013) Ivo Ditah et al.   JOURNAL OF HEPATOLOGY

Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

(2013) Jagpreet Chhatwal et al.   VALUE IN HEALTH

Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting

(2013) Magdalena Harris et al.   SOCIAL SCIENCE & MEDICINE

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

(2013) Elamin H. Elbasha et al.   Applied Health Economics and Health Policy

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

(2009) Nikolai Mühlberger et al.   BMC PUBLIC HEALTH